Eighteen states are suing North Chicago-based Abbott Laboratories, alleging the drug maker blocked generic competition for a popular cholesterol medication.
The federal antitrust lawsuit charges that Abbott and an unidentified French drug company (Fournier?) tried to block competition for a cheaper, generic version of the prescription drug TriCor. The cholesterol drug accounted for more than $1 billion of Abbott's sales last year.
The states allege that the companies continuously made minor changes in the formulations of TriCor to prevent generic versions from entering the market.
The Trib
No comments:
Post a Comment